File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Conference Paper: Understanding molecular mechanisms underlying leucine-rich repeat kinase 2 (LRRK2)-related Parkinson's disease

TitleUnderstanding molecular mechanisms underlying leucine-rich repeat kinase 2 (LRRK2)-related Parkinson's disease
Authors
Issue Date2012
PublisherElsevier Ltd. The Journal's web site is located at http://www.elsevier.com/locate/parkreldis
Citation
The 19th WFN World Congress on Parkinson's Disease and Related Disorders, Shanghai, China, 11–14 December 2011. In Parkinsonism & Related Disorders, 2012, v. 18 suppl. 2, p. S180-S181, abstract 3.048 How to Cite?
AbstractParkinson’s disease is a common neurodegenerative movement disorder. Mutation of LRRK2 is pathogenic in PD. More than 20 mutations of LRRK2 have been reported in Parkinson patients. Most importantly, 5–6% of familial PD patients harbor these mutations. Some of the mutations were shown to be able to increase LRRK2 kinase activity. Over-expression of LRRK2 in transgenic mice leads to tauopathy and hyperphosphorylated tau, indicating the pivotal role of LRRK2 in PD pathogenesis. We aim to elucidate the importance of LRRK2 in the pathogenesis of PD by studying the effects of this protein on neuronal cell death under oxidative stress. MATERIALS AND METHODS: We have generated LRRK2 knockin (KI) mice bearing the pathogenic point mutation R1441G of LRRK2 by inserting a targeting vector via homologous recombination into the murine LRRK2 locus. We compared the LRRK2 expression level, mitochondria number and movement ability in the KI mouse and control mouse lines. We characterized the LRRK2 R1441G KI mice and control mice by immunohistochemistry of tyrosine hydroxylase (TH) to identify TH+ neurons and measured mice behave after challenged with MPTP injection (IP) to induce nigrostriatal degeneration. RESULTS: Our preliminary data showed that LRRK2 R1441G induced a less degree of sensitivity to oxidative stress compared with that exhibited by the control mice induced by MPTP. The dopamine transporter should be affected or Impaired in this KI mice. The results of this study have important implication on understanding the LRRK2 funciton in the pathogenesis of PD.
DescriptionThis journal suppl. contatin Abstracts of WFN XIX World Congress on Parkinson's Disease and Related Disorders
Persistent Identifierhttp://hdl.handle.net/10722/182113
ISSN
2015 Impact Factor: 3.794
2015 SCImago Journal Rankings: 1.488

 

DC FieldValueLanguage
dc.contributor.authorLiu, Hen_US
dc.contributor.authorHo, PWLen_US
dc.contributor.authorHo, JWMen_US
dc.contributor.authorRamsden, DBen_US
dc.contributor.authorZhou, Len_US
dc.contributor.authorHo, SLen_US
dc.date.accessioned2013-04-17T07:22:01Z-
dc.date.available2013-04-17T07:22:01Z-
dc.date.issued2012en_US
dc.identifier.citationThe 19th WFN World Congress on Parkinson's Disease and Related Disorders, Shanghai, China, 11–14 December 2011. In Parkinsonism & Related Disorders, 2012, v. 18 suppl. 2, p. S180-S181, abstract 3.048en_US
dc.identifier.issn1353-8020-
dc.identifier.urihttp://hdl.handle.net/10722/182113-
dc.descriptionThis journal suppl. contatin Abstracts of WFN XIX World Congress on Parkinson's Disease and Related Disorders-
dc.description.abstractParkinson’s disease is a common neurodegenerative movement disorder. Mutation of LRRK2 is pathogenic in PD. More than 20 mutations of LRRK2 have been reported in Parkinson patients. Most importantly, 5–6% of familial PD patients harbor these mutations. Some of the mutations were shown to be able to increase LRRK2 kinase activity. Over-expression of LRRK2 in transgenic mice leads to tauopathy and hyperphosphorylated tau, indicating the pivotal role of LRRK2 in PD pathogenesis. We aim to elucidate the importance of LRRK2 in the pathogenesis of PD by studying the effects of this protein on neuronal cell death under oxidative stress. MATERIALS AND METHODS: We have generated LRRK2 knockin (KI) mice bearing the pathogenic point mutation R1441G of LRRK2 by inserting a targeting vector via homologous recombination into the murine LRRK2 locus. We compared the LRRK2 expression level, mitochondria number and movement ability in the KI mouse and control mouse lines. We characterized the LRRK2 R1441G KI mice and control mice by immunohistochemistry of tyrosine hydroxylase (TH) to identify TH+ neurons and measured mice behave after challenged with MPTP injection (IP) to induce nigrostriatal degeneration. RESULTS: Our preliminary data showed that LRRK2 R1441G induced a less degree of sensitivity to oxidative stress compared with that exhibited by the control mice induced by MPTP. The dopamine transporter should be affected or Impaired in this KI mice. The results of this study have important implication on understanding the LRRK2 funciton in the pathogenesis of PD.-
dc.languageengen_US
dc.publisherElsevier Ltd. The Journal's web site is located at http://www.elsevier.com/locate/parkreldis-
dc.relation.ispartofParkinsonism & Related Disordersen_US
dc.titleUnderstanding molecular mechanisms underlying leucine-rich repeat kinase 2 (LRRK2)-related Parkinson's diseaseen_US
dc.typeConference_Paperen_US
dc.identifier.emailLiu, H: liuhf@hku.hken_US
dc.identifier.emailHo, PWL: hwl2002@hku.hken_US
dc.identifier.emailHo, JWM: seeka@hku.hken_US
dc.identifier.emailHo, SL: slho@hku.hken_US
dc.identifier.authorityHo, PWL=rp00259en_US
dc.identifier.authorityHo, SL=rp00240en_US
dc.identifier.hkuros213955en_US
dc.identifier.volume18en_US
dc.identifier.issuesuppl. 2en_US
dc.identifier.spageS180, abstract 3.048en_US
dc.identifier.epageS181en_US
dc.publisher.placeUnited Kingdom-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats